Global Tropical Disease Testing Products Market, By Product and Services (Assays, Kits, and Reagents, Instruments, Services and Software), Disease Type (Hepatitis, HIV, CT/NG, HAIs, HPV, TB, Influenza, Other Diseases), Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing and NGS, DNA Microarrays, Other Technologies), End Use (Hospitals/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users) – Industry Trends and Forecast to 2029.
Tropical Disease Testing Products Market Analysis and Size
The tropical disease testing products ?market is expected to witness significant growth during the forecast period. The market growth factors include the rising prevalence of contagious infections worldwide, the shift from centralised labs to suburbanized POC (point-of-care testing), the growing understanding of personalised medicine, and expanding knowledge about customized medication. These factors are determining the market's expansion.
Data Bridge Market Research analyses that the tropical disease testing products market which was USD 16500 million in 2021, would rocket up to USD 24658.02 million by 2029, and is expected to undergo a CAGR of 5.15% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Tropical Disease Testing Products Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product and Services(Assays, Kits, and Reagents, Instruments, Services and Software), Disease Type (Hepatitis, HIV, CT/NG, HAIs, HPV, TB, Influenza, Other Diseases), Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing and NGS, DNA Microarrays, Other Technologies), End Use(Hospitals/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Johnson & Johnson Services Inc. (U.S.), Danaher (U.S.), ThermoFisher Scientific, Inc. (U.S.), Siemens (Germany), Abbott (U.S.), Bio-Rad Laboratories Inc. (U.S.), BD (U.S.), F. Hoffmann-La Roche AG (Switzerland), Hologic, Inc. (U.S.), Qiagen (Germany), Sofinas.a. (Belgium), Ingersoll-Rand (Ireland), Quest Diagnostics, Incorporated (U.S.), Cardinal Health (U.S.), Quidel Corporation (U.S.), Trinity Biotech (Ireland)
|
|
Market Opportunities
|
|
Market Definition
Tropical diseases are contagious illnesses that thrive in warm, muggy weather, which is conducive to the development of parasites, fungus, bacteria, and viruses. The population of insects and other vectors that spread disease infections, such as mosquitoes, is also thriving. If they are identified early and the appropriate medical measures are performed, many lives can be spared. Tropical disease testing is any disease indigenous to tropical or subtropical areas of the world. Examples of tropical diseases include malaria, cholera, Chagas disease, yellow fever, and dengue.
Tropical Disease Testing Products Market Dynamics
Drivers
- Government Initiatives
In Burundi, the government’s involvement caused a domino effect, resulting in match-funding from partners from all over the world. These initiatives reinforced the importance of building strong strategic partnerships. Through collaboration, the NTD programme was able to more efficiently use resources, save on logistical costs and, most importantly, reach many people.
- Rising contagious infections
The rising prevalence of contagious infections worldwide, the shift from centralised labs to suburbanized POC (point-of-care testing), the growing understanding of personalised medicine, and expanding knowledge about customized medication. These factors are determining the market's expansion.
Opportunities
- Increase in the number of research and development activities
Some of the factors, such as ineffective pay practises and rising healthcare costs that limit the use of cutting-edge diagnostic techniques, may act as a restraint during a period of corporate expansion to slow the growth of exchange.
Restraints/Challenges
On the other hand, the limited number of trained healthcare professionals with the proficiency to diagnose and interpret the tropical infectious diseases by techniques like RT- PCR, immunoassay, hematology will restrain the market’s growth.
This tropical disease testing products market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tropical disease testing products market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Tropical Disease Testing Products Market
The COVID-19 epidemic has slightly influenced healthcare systems and the market. Rapid diagnostic tests (RDTs) and molecular testing for numerous tropical diseases have put their development and production on hold due to the urgent requirement to create diagnostics for COVID-19 during the pandemic. One tactic used by ministries of health to stop transmission and reduce the frequency is contact tracing for all individuals with laboratory-confirmed COVID-19. Other diseases have seen great success with this strategy. For instance, the mainstays of the fight against leprosy have been early case diagnosis (via contact tracing) and timely treatment. Programs to eradicate visceral leishmaniasis in the Indian subcontinent have also depended on 'fever camps' to identify patients with fever.
Global Tropical Disease Testing Products Market Scope
The tropical disease testing products market is segmented on the basis of product and services, disease type, technology and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Assays
- Kits
- Reagents
- Instruments
- Services
- Software
Disease Type
Technology
- Immunodiagnostics
- Clinical Microbiology
- PCR, INAAT
- DNA Sequencing
- NGS
- DNA Microarrays
- Other Technologies
End Use
- Hospitals/Clinical Laboratories
- Reference Laboratories
- Physician Offices
- Academic/Research Institutes
- Other End Users
Tropical Disease Testing Products Market Regional Analysis/Insights
The tropical disease testing products market is analysed and market size insights and trends are provided by country, product and services, disease type, technology and end use as referenced above.
The countries covered in the tropical disease testing products market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the tropical disease testing products market due to profoundly advanced healthcare arrangement, progressing pervasiveness of communicable infections, and the occupancy of a huge quantity of supervising nationwide clinical labs.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to high population base, development in healthcare infrastructure, rise in awareness, and increase in government initiatives.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The tropical disease testing products market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Global Hi-tech medical devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tropical disease testing products market. The data is available for historic period 2010-2020.
Competitive Landscape and Tropical disease testing products Market Share Analysis
The tropical disease testing products market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tropical disease testing products market.
Some of the major players operating in the tropical disease testing products market are:
- Johnson & Johnson Services Inc. (U.S.)
- Danaher (U.S.)
- ThermoFisher Scientific, Inc. (U.S.)
- Siemens (Germany)
- Abbott (U.S.)
- Bio-Rad Laboratories Inc. (U.S.)
- BD (U.S.)
- F. Hoffmann-La Roche AG (Switzerland)
- Hologic, Inc. (U.S.)
- Qiagen (Germany)
- Sofinas (Belgium)
- Ingersoll-Rand (Ireland)
- Quest Diagnostics Incorporated (U.S.)
- Cardinal Health (U.S.)
- Quidel Corporation (U.S.)
- Trinity Biotech (Ireland)
SKU-